BEAM
#1719
Beam Therapeutics Inc. - Common Stock
29.3 2 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.81%
Changement Mensuel
+14.76%
Evolution sur 6 mois
+7.05%
Changement Annuel
+81.10%
Clôture Précédente
30.4 8
Open
29.3 2
Low
29.3 2
High
29.3 2
Volume
155
Financials
- Market Capitalization 3.03 B
- Employee 540
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-51.22
ratio cours/chiffre d'affaires
22
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1703 |  IRON Disc Medicine, Inc. - Common Stock | 80.03 USD | -3.05% | +0.19% | +3.94% | +34.46% | 3.07 B USD | ||
| 1704 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.12 USD | -3.31% | -2.59% | +2.70% | +43.61% | 3.07 B USD | ||
| 1727 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 23.78 USD | -4.38% | -4.11% | -10.84% | +53.82% | 2.99 B USD | ||
| 1741 |  ZLAB Zai Lab Limited - American Depositary Shares | 26.08 USD | -2.76% | +2.35% | +42.51% | -2.29% | 2.93 B USD |